Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Scientific Reports|July 10, 2019
Tissue amino acid profiles are characteristic of tumor type, malignant phenotype, and tumor progression in pancreatic tumorsNobuyoshi Hiraoka, Sakino Toue, Chisato Okamoto, et al.
Virchows Archiv : an International Journal of Pathology|October 7, 2016
Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinomaShutaro Hori, Kazuaki Shimada, Yoshinori Ino, et al.
Anticancer Research|April 12, 2015
Bevacizumab and postoperative wound complications in patients with liver metastases of colorectal cancerHirofumi Utsumi, Yoshitaka Honma, Kengo Nagashima, et al.
Cancer Science|June 5, 2020
Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patientsNobuyoshi Hiraoka, Yoshinori Ino, Shutaro Hori, et al.
Journal of Gastroenterology|September 13, 2021
APC mutations are common in adenomas but infrequent in adenocarcinomas of the non-ampullary duodenumKenichi Ishizu, Taiki Hashimoto, Tomoaki Naka, et al.
Journal of Proteomics|December 14, 2011
Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinomaNoriaki Morofuji, Hidenori Ojima, Hiroaki Onaya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 18, 2013
Early venous return in hepatic angiomyolipoma due to an intratumoral structure resembling an arteriovenous fistulaYasuhito Iwao, Hidenori Ojima, Hiroaki Onaya, et al.
The American Journal of Surgical Pathology|March 17, 2021
Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases: A Proposal of Risk Stratification and Identification of a Synaptophysin-positive Aggressive SubsetTakahiro Shibayama, Naohiro Makise, Toru Motoi, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 7, 2012
Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapyTomoko Katsui Taniyama, Chigusa Morizane, Kohei Nakachi, et al.
Abdominal Radiology (New York)|August 9, 2024
Safety and feasibility of percutaneous abdominal lavage cytology screening (PACS) prior to surgical resection for pancreatic cancerShunsuke Sugawara, Miyuki Sone, Ryosuke Umino, et al.
Pageof 15